Is Option B+ the best choice? – Authors' reply

Authors :: Peter Barron
Anna Coutsoudis
Ameena Ebrahim Goga
Hoosen Coovadia
Vivian Black
Chris Desmond
Source :: The Lancet. 381:1273-1274
Publication Year :: 2013
Publisher :: Elsevier BV, 2013.

Subjects :: Anti-Retroviral Agents
Pregnancy
business.industry
Humans
Medicine
Female
HIV Infections
General Medicine
Pregnancy Complications, Infectious
business
Infectious Disease Transmission, Vertical

Tools